Literature DB >> 10537781

Ocular manifestations of cat-scratch disease.

L D Ormerod1, J P Dailey.   

Abstract

Bartonella henselae has only recently been isolated, characterized, and found to be the principal cause of cat-scratch disease (CSD). The availability of specific serologic investigations has allowed the recognition of a spectrum of ocular CSD syndromes that previously were ill defined and considered idiopathic. The primary inoculation complex causing regional lymphadenopathy is represented in the eye by Parinaud's oculoglandular syndrome; B. henselae is the most common cause. Leber's neuroretinitis has been identified for 80 years, and new data suggest that it is commonly a manifestation of CSD; the extent of the association remains to be determined. CSD optic neuritis is also described. The vitreoretinal manifestations include anterior uveitis, vitritis, pars planitis, focal retinal vasculitis, a characteristic retinal white spot syndrome, Bartonella retinitis, branch retinal arteriolar or venular occlusions, focal choroiditis, serous retinal detachments, and peripapillary angiomatous lesions. The pattern of ocular disease in AIDS-associated B. henselae infections is poorly delineated; unusual manifestations include conjunctival and retinal bacillary angiomatosis. The benefit of antimicrobial therapy for CSD in immunocompetent individuals has been difficult to establish, partly because most infections are self limited. Empirically, azithromycin, ciprofloxacin, rifampin, parenteral gentamicin, or trimethoprim-sulfamethoxazole provide the best therapeutic choices to minimize damage to the eye.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537781     DOI: 10.1097/00055735-199906000-00010

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  39 in total

1.  [Parinaud's oculoglandular syndrome. A rare differential diagnosis of "red eye"].

Authors:  M C Jäckel; T Glock; A Künster
Journal:  HNO       Date:  2006-01       Impact factor: 1.284

2.  Ocular manifestations of cat-scratch disease: role of MR imaging.

Authors:  Mahmood F Mafee
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

3.  Secondary unilateral glaucoma and neuroretinitis: atypical manifestation of cat-scratch disease.

Authors:  Focke Ziemssen; Karl-Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.447

4.  Pattern visual evoked potentials in eyes with disc swelling due to cat scratch disease-associated neuroretinitis.

Authors:  Yuzhu Chai; Shuichi Yamamoto; Atsuko Hirayama; Jiro Yotsukura; Hiroko Yamazaki
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

5.  Cat Scratch Disease: Expanded Spectrum.

Authors:  Hassan A Aziz; Thomas P Plesec; Camille Sabella; Unni K Udayasankar; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2016-07-01

6.  Intraocular detection of Bartonella henselae in a patient with HLA-B27 uveitis.

Authors:  Michel Drancourt; Bahram Bodaghi; Hubert Lepidi; Phuc Le Hoang; Didier Raoult
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 7.  Treatment of ocular inflammation in children.

Authors:  Sunil M Thadani; C Stephen Foster
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 8.  Oculo-renal disorders in infectious diseases.

Authors:  Hassane Izzedine; Irina Buhaescu; Bahram Bodaghi; Valerie Martinez; Eric Caumes; Phuc Lehoang; Gilbert Deray
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

Review 9.  Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome.

Authors:  Jyotirmay Biswas; S Sudharshan
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

10.  Neuroretinitis, a great mimicker.

Authors:  Sunil K Narayan; Subashini Kaliaperumal; Renuka Srinivasan
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.